<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 2, 2000
---------------
RENAL CARE GROUP, INC.
----------------------
(Exact name of registrant as specified in its charter)
Delaware 0-27640 62-1622383
-------------- ---------- ------------
(State or other (Commission (IRS Employer
jurisdiction of File Number) Identification No.)
incorporation)
2100 West End Avenue, Suite 800, Nashville, Tennessee 37203
-----------------------------------------------------------
(Address, including zip code, of principal executive offices)
(615) 345-5500
--------------------------------------------------
(Registrant's telephone number, including area code)
<PAGE> 2
Item 5. Other Events.
On October 2, 2000, Renal Care Group, Inc. (the "Company") issued a
press release announcing that the Board of Directors authorized the Company to
expend up to $50 million to repurchase the Company's common stock. Such press
release is attached hereto as Exhibit 99.1.
Item 7. Financial Statements and Exhibits.
(a) None.
(b) None.
(c) Exhibits.
99.1 Press Release issued October 2, 2000, regarding the
repurchase of the Company's common stock.
<PAGE> 3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
RENAL CARE GROUP, INC.
By: /s/ R. Dirk Allison
-----------------------
Name: R. Dirk Allison
-----------------------
Title: Chief Financial Officer
-----------------------
Date: October 2, 2000
